ReviewCell communication and signaling : CCS2026
Tumor cell intrinsic mechanisms of immune escape.
Review in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Cancer arises in a multi-step process involving acquisition of mutations, activation of oncogenes and the loss of tumor suppressive mechanisms in normal cells. Such intrinsic genetic events lead to cellular transformation and gain of aggressive traits including enhanced proliferation and survival, as well as invasion and metastasis of tumor cells. Recent evidence suggests that tumor cell-intrinsic signaling pathways can also lead to suppression of the immune response against tumor cells resulting in failure of cancer cells to be recognized and eliminated by the host immune system. Insights into the tumor-intrinsic mechanisms of immune escape will not only expand our understanding of tumor development and progression but help develop new combinations of therapeutic strategies in immuno-oncology to better align them with targeted therapeutics. Historically, the literature on oncogenes and tumor suppressor mechanisms has focused on signaling pathways leading to tumor cell proliferation, survival, and metastasis. Here, in this special thematic collection published in Cell Communication and Signaling ( https://link.springer.com/collections/dbbfcgaece ), we featured commentaries, review articles, and primary research articles that highlight recent work focused on the molecular and mechanistic links between intrinsic oncogenic signaling and mechanisms of immune escape. We conclude with commentary and open questions and challenges that remain in this emerging field.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.